Back to Authors

Maretzky, Thorsten

https://orcid.org/0000-0003-1282-6080

Mayo Clinic

Arthritis and Tissue Degeneration Program and

Citations 2

iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling
Li, Xue , Maretzky, Thorsten , Weskamp, Gisela, Monette, Sébastien , Qing, Xiaoping, Issuree, Priya D. , McIlwain, David R. , Mak, Tak W. , Blobel, Carl , Crawford, Howard C, Crawford, Howard C. , Salmon, Jane E.

Proceedings of the National Academy of Sciences | April 30, 2015 | Volume: 112 | Issue: 19 | Pages: 6080-6085

10.1073/pnas.1505649112 Get It

Significance The skin and intestinal barrier are controlled by signaling scissors, termed ADAM17 (a disintegrin and metalloprotease 17), that reside in the membrane on the surface of cells. The main purpose of these signaling scissors is to liberate growth factors from their membrane anchor, allowing them to activate their receptors, including the epidermal growth factor receptor (EGFR). The ADAM17/EGFR signaling axis is tightly regulated, yet little is known about the underlying mechanism. Here we use genetic, cell biological, and biochemical approaches to identify two membrane proteins termed iRhoms 1 and 2 (inactive Rhomboid-like proteins) as crucial upstream regulators of ADAM17-dependent EGFR signaling. This uncovers the iRhoms as attractive novel targets to treat ADAM17/EGFR-dependent diseases such as cancer.
ADAM17 Controls Endochondral Ossification by Regulating Terminal Differentiation of Chondrocytes
Hall, K. , Hill, Daniel, Otero, Miguel , Plumb, Darren A., Froemel, Dara, Dragomir, C., Maretzky, Thorsten , Boskey, Adele L. , Selleri, Licia , Blobel, Carl , Crawford, Howard C. , Goldring, Mary B.

Molecular and Cellular Biology | June 4, 2013 | Volume: 33 | Issue: 16 | Pages: 3077-3090

10.1128/mcb.00291-13 Get It